Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2022
10 years of board service in total across 3 boards, counting each seat separately. Longest: CNS Pharmaceuticals Inc., 3 years.
CNS Pharmaceuticals Inc.
Director
Abeona Therapeutics Inc.
Director
CDT Equity Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | CNS Pharmaceuticals Inc. | Open-market purchase | +7,100 | $4.79 | $34,009 |
| Jan 26, 2026 | Abeona Therapeutics Inc. | Grant or award | +37,313 | — | — |
| Jul 9, 2025 | Abeona Therapeutics Inc. | Open-market sale | −10,738 | $5.86 | $62,925 |
| Apr 16, 2025 | CDT Equity Inc. | Grant or award | +115,194 | $0.87 | $100,219 |
| Mar 30, 2025 | CDT Equity Inc. | Grant or award | +46,629 | $0.89 | $41,500 |
| Jan 31, 2025 | Abeona Therapeutics Inc. | Grant or award | +36,101 | — | — |
| Nov 18, 2024 | CDT Equity Inc. | Grant or award | +75,000 | — | — |
| Nov 18, 2024 | CDT Equity Inc. | Grant or award | +266,594 | $0.09 | $23,993 |
| Aug 26, 2024 | Abeona Therapeutics Inc. | Grant or award | +11,797 | — | — |
| Jul 8, 2024 | Abeona Therapeutics Inc. | Grant or award | +23,611 | — | — |
| Apr 26, 2024 | Abeona Therapeutics Inc. | Open-market purchase | +7,550 | $3.28 | $24,764 |
| Sep 27, 2023 | Abeona Therapeutics Inc. | Open-market sale | −8,330 | $4.91 | $40,900 |
| Jun 14, 2023 | Abeona Therapeutics Inc. | Grant or award | +58,689 | $4.62 | $271,143 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.